黑料网官网

Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd., also known as Asymchem, is a leading Contract Development and Manufacturing Organization (CDMO) that supports the global pharmaceutical industry. The company offers comprehensive services throughout the drug development process, including research, development, and production of new drugs. Its services span from early clinical stages to full commercialization, including the development of advanced intermediates, raw materials, formulations, and clinical research services. Founded in 1998 and headquartered in Tianjin, the company has expanded its capabilities through strategic partnerships and continues to focus on technological innovation. Kailaiying is publicly traded on both the Shenzhen Stock Exchange (stock code: 002821.SZ) and the Hong Kong Stock Exchange (6821.HK). The company’s mission is to accelerate drug launches and enhance the quality of life by providing efficient and reliable pharmaceutical solutions to biotech and pharma clients globally.